2018-2023 Global & French Pharma Markets
This abstract, available by clicking on this link:
1. Reviews international healthcare expenditure.
2. Estimates the likely evolution of the global and the French pharma markets by 2023.
3. Highlights R&D expenditures and key projects.
4. Analyses the top 30 pharma companies performance and strategy (e.g. portfolio, geographical coverage, M&A).
5. Proposes a SWOT analysis and a one-page strategic implications for pharma companies.